1-16 of 16
Christoph Scheid
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Neoplasms with Accompanying Paroxysmal Nocturnal Hemoglobinuria - a Study on Behalf of Cmwp and Saawp of the EBMT

Joanna Drozd-Sokolowska, Patrick Gilbert, Joe Tuffnell, Linda Koster, Uwe Platzbecker, Grzegorz Helbig, Pavel Jindra, Carlo Borghero, Matthias Eder, Thomas Schroeder, Katja Sockel, Thomas Cluzeau, Cecilia Isaksson, Nicolaus Kröger, Nuno Miranda, Montserrat Rovira, Urpu Salmenniemi, Henrik Sengeloev, Simona Sica, Peter A. Von Dem Borne, Francesco Onida, Carmelo Gurnari, Christoph Scheid, Kavita K Raj, Regis Peffault De Latour, Antonio M Risitano, Marie Robin, Donal P McLornan
Journal: Blood
Blood (2024) 144 (Supplement 1): 4949.
https://doi.org/10.1182/blood-2024-203009
Published: 2024
Journal Articles

Conditioning Intensity in Patients Aged > 50 Years Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrom: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT

Noureddine Henoun Loukili, Luuk Gras, Sr., Linda Koster, Didier Blaise, Tobias Gedde-Dahl, Johan Maertens, Regis Peffault De Latour, Henrik Sengeloev, Stephan Mielke, Patrice Chevallier, Jakob R. Passweg, Jenny Louise Byrne, Urpu Salmenniemi, Anne Sirvent, Denis Guyotat, Simona Sica, Liesbeth C. de Wreede, Francesco Onida, Christoph Scheid, Carmelo Gurnari, Joanna Drozd-Sokolowska, Kavita Raj, Marie Robin, Donal P McLornan, Ibrahim Yakoub-Agha
Journal: Blood
Blood (2023) 142 (Supplement 1): 472.
https://doi.org/10.1182/blood-2023-172796
Published: 2023
Journal Articles

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in Patients with High-Risk Newly Diagnosed Multiple Myeloma: Planned Interim Analysis of the GMMG-Concept Trial

Katja Weisel, Britta Besemer, Mathias Haenel, Raphael Lutz, Christoph Mann, Markus Munder, Martin Goerner, Hans Christian Reinhardt, Axel Nogai, Yon-Dschun Ko, Maike De Wit, Hans Salwender, Christoph Scheid, Ullrich Graeven, Rudolf Peceny, Peter Staib, Annette Dieing, Anna Jauch, Manola Zago, Axel Benner, Diana Tichy, Carsten Bokemeyer, Hartmut Goldschmidt, Lisa B. Leypoldt
Journal: Blood
Blood (2022) 140 (Supplement 1): 1836–1838.
https://doi.org/10.1182/blood-2022-156309
Published: 2022
Journal Articles

Characterization and T-Cell Repertoire of MB-CART2019.1 (Zamtocabtagene autoleucel) - Data from the Phase I Trial in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Tatjana Holzer, Stefanie Biedermann, Inga Herfort, Birte Friedrichs, Silke Holtkamp, Linda Hanssens, Mario Assenmacher, Ulf Bethke, Dina Schneider, Stefan Miltenyi, Toon Overstijns, Christoph Schmid, Francis A. Ayuk, Christoph Scheid, Anja Jühling, Udo Holtick, Philipp Gödel, Peter Borchmann, Iris Bürger
Journal: Blood
Blood (2022) 140 (Supplement 1): 4581–4583.
https://doi.org/10.1182/blood-2022-164597
Published: 2022
Journal Articles

Genomic Landscape and Molecular Risk in Patients with Advanced Myelofibrosis Treated within the Multicenter Phase Ib/II MPNSG0212 (POMINC) Trial

Ekaterina Panina, Steffen Koschmieder, Florian H. Heidel, Andreas Hochhaus, Holger Hebart, Susanne Isfort, Frank G. Rücker, Andreas Reiter, Markus Bangerter, Cornelius Waller, Christoph Scheid, Denise Wolleschak, Joachim R. Goethert, Philippe Schafhausen, Thomas Kindler, Markus P. Radsak, Norbert Gattermann, Robert Möhle, Nikolas von Bubnoff, Tim H Brümmendorf, Hartmut Döhner, Martin Griesshammer, Frank Stegelmann, Konstanze Döhner
Journal: Blood
Blood (2021) 138 (Supplement 1): 4637.
https://doi.org/10.1182/blood-2021-150361
Published: 2021
Journal Articles

Treatment of MDS, AML and CMML Relapse after Allogeneic Blood Stem Cell Transplantation with Azacitidine, Lenalidomide and Donor Lymphocyte Infusions - Final Results of the Prospective Azalena-Trial (NCT02472691)

Thomas Schroeder, Matthias Stelljes, Maximilian Christopeit, Eva Schmidt, Christoph Scheid, Jan-Henrik Mikesch, Christina Rautenberg, Paul Jäger, Nadja Drusenheimer, Udo Holtick, Stefan Klein, Rudolf Trenschel, Rainer Haas, Ulrich Germing, Nicolaus Kröger, Guido Kobbe
Journal: Blood
Blood (2021) 138 (Supplement 1): 411.
https://doi.org/10.1182/blood-2021-153282
Published: 2021
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT

Marie Robin, MD, Junfeng Wang, PhD, Linda Koster, Dietrich W. Beelen, Martin Bornhäuser, MD, Nicolaus Kroeger, MD, Uwe Platzbecker, Jürgen Finke, MD, Arnold Ganser, MD, Didier Blaise, MD PhD, Fabio Ciceri, MD, Johan Maertens, Helene Labussiere-Wallet, MD, Patrice Chevallier, MD, Jakob R. Passweg, MD, Jan J Cornelissen, MD PhD, Noel Milpied, MD, Amandine Charbonnier, MD, Francesca Bonifazi, Liesbeth C. de Wreede, PhD, Patrick Hayden, Christoph Scheid, MD, Ibrahim Yakoub-Agha, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 45.
https://doi.org/10.1182/blood-2019-124765
Published: 2019
Journal Articles

Updated Results from the German Mpnsg-0212 Combination Trial: Ruxolitinib Plus Pomalidomide in Myelofibrosis with Anemia

Frank Stegelmann, MD, Steffen Koschmieder, Susanne Isfort, Andreas Hochhaus, MD, Florian H. Heidel, Holger Hebart, Markus Bangerter, Denise Wolleschak, Christoph Scheid, MD, Joachim R Göthert, PD, MD, Philippe Schafhausen, Thomas Kindler, MD, Markus P. Radsak, MD, Robert Möhle, MD, Cornelius Waller, Nikolas von Bubnoff, Andreas Reiter, Hartmut Döhner, MD, Martin Griesshammer, MD, Konstanze Döhner
Journal: Blood
Blood (2019) 134 (Supplement_1): 672.
https://doi.org/10.1182/blood-2019-127859
Published: 2019
Journal Articles

Salvage Autologous Transplant and Lenalidomide Maintenance Versus Continuous Lenalidomide/Dexamethasone for Relapsed Multiple Myeloma: Results of the Randomized GMMG Phase III Multicenter Trial Relapse

Hartmut Goldschmidt, MD, Marc-A. Baertsch, MD, Jana Schlenzka, MD, Natalia Becker, PhD, Habermehl Christina, PhD, Thomas Hielscher, Marc S Raab, MD, Jens Hillengass, MD, Carsten Müller-Tidow, MD, Steffen Luntz, MD, Anna Jauch, PhD, Peter Brossart, MD, Martin Goerner, MD, Stefan A Klein, MD, Martin Schmidt-Hieber, MD PhD, Peter Reimer, MD, Ullrich Graeven, MD, Roland Fenk, MD PhD, Mathias Haenel, MD, Hans Martin, MD, Hans-Walter Lindemann, MD, Christoph Scheid, MD, Axel Nogai, MD, Hans Jürgen Salwender, MD, Richard Noppeney, MD, Katja Weisel, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 253.
https://doi.org/10.1182/blood-2018-99-111203
Published: 2018
Journal Articles

Subgroup Analyses of the Randomized GMMG Phase III Multicenter Trial Relapse Suggest Survival Benefit of Salvage Autologous Transplant Primarily in Low Risk Multiple Myeloma

Marc-A. Baertsch, MD, Jana Schlenzka, MD, Habermehl Christina, PhD, Thomas Hielscher, Marc S Raab, MD, Jens Hillengass, MD, Carsten Müller-Tidow, MD, Steffen Luntz, MD, Anna Jauch, PhD, Peter Brossart, MD, Martin Goerner, MD, Stefan A Klein, MD, Martin Schmidt-Hieber, MD PhD, Peter Reimer, MD, Ullrich Graeven, MD, Roland Fenk, MD PhD, Mathias Haenel, MD, Hans Martin, MD, Hans-Walter Lindemann, MD, Christoph Scheid, MD, Axel Nogai, MD, Hans Jürgen Salwender, MD, Richard Noppeney, MD, Katja Weisel, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 254.
https://doi.org/10.1182/blood-2018-99-119762
Published: 2018
Journal Articles

Treatment of MDS, AML and CMML Relapse after Allogeneic Blood Stem Cell Transplantation with Azacitidine, Lenalidomide and Donor Lymphocyte Infusions Results from the Second Interim Analysis of the Prospective Azalena-Trial (NCT02472691)

Thomas Michael Schroeder, MD PhD, Christina Rautenberg, MD, Max Christopeit, Matthias Stelljes, MD, Eva Schmidt, Christoph Groth, MD, Christoph Scheid, MD, Udo Holtick, MD PhD, Stefan A Klein, MD, Dietrich W. Beelen, Kathrin Nachtkamp, MD, Rainer Haas, MD, Ulrich Germing, MD, Nicolaus Kröger, MD, Guido Kobbe
Journal: Blood
Blood (2018) 132 (Supplement 1): 703.
https://doi.org/10.1182/blood-2018-99-113776
Published: 2018
Journal Articles

Reduced Intensity Vs. Myeloablative Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with Myelodysplastic Syndrome: Long Term Follow-up of a Prospective Randomized EBMT Phase III Study (RICMAC-Trial)

Nicolaus Kroeger, MD, Simona Iacobelli, PhD, Linda Koster, Dietger Niederwieser, MD, Uwe Platzbecker, Kai Huebel, MD, Christoph Scheid, MD, Thomas Weber, MD, Matthias Stelljes, MD, Boris Afanasiev, MD, Dominik Heim, MD, Giorgio Lambertenghi Deliliers, MD, Francesco Onida, MD, Peter Dreger, MD, Massimo Pini, MD, Stefano Guidi, MD, Liisa Volin, MD, Andreas Guenther, MD, Wolfgang Bethge, MD, Xavier Poire, MD, Guido Kobbe, Marleen van Os, Ibrahim Yakoub-Agha, MD PhD, Marie Robin, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1019.
https://doi.org/10.1182/blood-2018-99-113340
Published: 2018
Journal Articles

Outcome of Patients with Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Beyond First Complete Remission (CR1)

Georg Evers, MD, Dietrich W. Beelen, Jan Braess, MD, Cristina Sauerland, Hans-Jochem Kolb, MD, Albrecht Reichle, MD, Ernst Holler, MD, Rainer Schwerdtfeger, MD, Renate Arnold, MD, Christoph Scheid, MD, Utz Krug, MD, Carsten Müller-Tidow, MD, Christoph Schliemann, MD, Jan-Henrik Mikesch, MD, Georg Lenz, Bernhard J. Wörmann, MD, Wolfgang Hiddemann, Wolfgang E. Berdel, MD, Matthias Stelljes, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4649.
https://doi.org/10.1182/blood-2018-99-116964
Published: 2018
Journal Articles

Prospective Multicenter Phase 3 Study Comparing 5-Azacytidine (5-Aza) Induction Followed By Allogeneic Stem Cell Transplantation Versus Continuous 5-Aza According to Donor Availability in Elderly MDS Patients (55-70 years) (VidazaAllo Study)

Nicolaus Kroeger, Katja Sockel, MD, Christine Wolschke, MD, Wolfgang Bethge, MD, Richard F. Schlenk, MD, Dominik Wolf‎, MD, Michael Stadler, MD PhD, Guido Kobbe, Gerald Wulf, MD, Gesine Bug, Kerstin Schäfer-Eckart, MD, Christoph Scheid, MD, Florian Nolte, MD, Jan Krönke, MD, Matthias Stelljes, MD, Dietrich W. Beelen, Marion Heinzelmann, Detlef Haase, MD PhD, Hannes Buchner, Dr., Gabriele Bleckert, Dr., Uwe Platzbecker
Journal: Blood
Blood (2018) 132 (Supplement 1): 208.
https://doi.org/10.1182/blood-2018-99-115932
Published: 2018
Journal Articles

Changes in the T and B- Cell Subsets Following Treatment with a CD25-Antibody in Patients with Steroid Refractory GvHD

Geothy Chakupurakal, MBBS, MRCPath, PhD, Maria Garcia- Marquez, Alexander Shimabukuro- Vornhagen, MD, Hans Anton Schloesser, MD, Udo Holtick, MDPhD, Christoph Scheid, MD PhD, Michael von Bergwelt-Baildon, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2497.
https://doi.org/10.1182/blood.V124.21.2497.2497
Published: 2014
Journal Articles

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation

Christoph Schmid, Michael Schleuning, Rainer Schwerdtfeger, Bernd Hertenstein, Eva Mischak-Weissinger, Donald Bunjes, Stephanie v. Harsdorf, Christoph Scheid, Udo Holtick, Hildegard Greinix, Felix Keil, Barbara Schneider, Michael Sandherr, Gesine Bug, Johanna Tischer, Georg Ledderose, Michael Hallek, Wolfgang Hiddemann, Hans-Jochem Kolb
Journal: Blood
Blood (2006) 108 (3): 1092–1099.
https://doi.org/10.1182/blood-2005-10-4165
Published: 2006